![Yaron Pereg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Yaron Pereg
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
KAHR Medical Ltd.
![]() KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel.
11
| Holding Company | Pharmaceuticals: Major | 11 |
Extinct | Medical Specialties | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Yaron Pereg tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Ramot at Tel Aviv University Ltd.
![]() Ramot at Tel Aviv University Ltd. Miscellaneous Commercial ServicesCommercial Services Ramot at Tel Aviv University Ltd. operates as a technology transfer company of Tel Aviv University (TAU). It provides legal and commercial frameworks for inventions made by TAU faculty, students, and researchers. The firm licenses the university's intellectual property to third parties through agreements; facilitates collaborative research partnerships between business partners and TAU researchers; establishes a company; and forms joint ventures that promote TAU technologies. The company was founded in 1973 and is headquartered in Tel Aviv, Israel. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Provell Pharmaceuticals LLC
![]() Provell Pharmaceuticals LLC Medical DistributorsDistribution Services Provell Pharmaceuticals LLC is a healthcare company, which engages in marketing and distribution of pharmaceutical products. It offers products of Merck KGaA including Euthyrox. The company was founded by Jim Small and Kurt Kalm in 2005 and is headquartered in Honey Brook, PA. | Medical Distributors | Director/Board Member Director/Board Member | |
Morgan Stanley & Co. LLC
![]() Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry. | Investment Banks/Brokers | Analyst-Equity | |
RECIPHARM AB (PUBL) | Biotechnology | Chief Tech/Sci/R&D Officer Founder | |
University of Michigan | College/University | Masters Business Admin Graduate Degree | |
Hadasit Medical Research Services & Development Ltd.
![]() Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Hadasit Medical Research Services & Development Ltd. operates as technology transfer company of Hadassah Medical Center in Jerusalem. It identifies, protects, nurtures and commercializes the discoveries made at Hadassah Medical Center. The company's product include Doxil, Periochip, Travelan, Granagard, and Insupad. The company was founded on December 7, 1986 and is headquartered in Jerusalem, Israel. | Miscellaneous Commercial Services | Chief Executive Officer | |
Recipharm Monts SAS
![]() Recipharm Monts SAS Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm Monts SAS is a company that manufactures sterile injectable anesthetic products. The company is based in Monts, France. Carl Ericson has been the CEO of the French company since 2019. | Pharmaceuticals: Major | Chairman | |
XENIA VENTURE CAPITAL LTD | Financial Conglomerates | Director/Board Member Director/Board Member | |
HBL - HADASIT BIO-HOLDINGS LTD | Investment Managers | Chief Executive Officer Chairman Director/Board Member | |
SymCel AB
![]() SymCel AB Medical SpecialtiesHealth Technology SymCel AB develops and markets analytical instrumentations for cell biological research and development. Its products include calScreener, calPlate System, and calView date collection and analysis software. The company was founded by Dan Rolf Stefan Hallen and Bertil Ingemar Wadso in 2004 and is headquartered in Spanga, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
Aesica Formulation Development Ltd.
![]() Aesica Formulation Development Ltd. Pharmaceuticals: MajorHealth Technology Aesica Formulation Development Ltd. develops pharmaceutical products. It offers sterile and nutraceutical product development and drug delivery services. The company was founded on December 22, 2005 and is headquartered in Northumberland, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
SwedenBIO Service AB
![]() SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Cobra Biologics Ltd.
![]() Cobra Biologics Ltd. Pharmaceuticals: MajorHealth Technology Cobra Biologics Ltd. engages in development of DNA-based technologies, services and products. It is a international contract development and manufacturing organization (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply. The company was founded in 1992 and is headquartered in Keele, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Recipharm Ltd.
![]() Recipharm Ltd. Pharmaceuticals: MajorHealth Technology Recipharm Ltd. manufactures pharmaceutical products. It offers branded and generic products. The company was founded on August 10, 2012 and is headquartered in Ashton-under-Lyne, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Recipharm Strängnäs AB
![]() Recipharm Strängnäs AB Miscellaneous Commercial ServicesCommercial Services Part of Recipharm AB, Recipharm Strängnäs AB is a contract development and manufacturing organization in the pharmaceutical industry. The company is based in Strängnäs, Sweden. Founded in 2004, Recipharm Strängnäs operates as a contract development and manufacturing organization in the pharmaceutical industry. | Miscellaneous Commercial Services | Director/Board Member | |
Recip AB
![]() Recip AB Pharmaceuticals: MajorHealth Technology Part of Viatris, Inc., Recip AB is a company that manufactures pharmaceutical products. Recip AB is based in Arsta, Sweden. Recip was acquired by Meda AB, part of Viatris, Inc. from August 24, 2016 on December 31, 2007 for $475.65 million. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Zentricity International AB
![]() Zentricity International AB Financial ConglomeratesFinance Zentricity International AB provides investment services. The private company is based in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
Cobra Biologics Holding AB
![]() Cobra Biologics Holding AB Pharmaceuticals: MajorHealth Technology Cobra Biologics Holding AB manufactures biologics and pharmaceuticals for pre-clinical, clinical, and commercial products. Its services include gene therapies and vaccines, products for testing, process development and scale up of vaccine products, production of sterile drug products, and process development and production, automation, and traceability of programs. The company was founded in 2011 and is headquartered in S?dert?lje, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Aesica Holdco Ltd.
![]() Aesica Holdco Ltd. Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Aesica Holdco Ltd. operates as a holding British company. The company is based in Hemel Hempstead, UK. | Pharmaceuticals: Major | Director/Board Member | |
FOLLICUM AB (PUBL) | Pharmaceuticals: Major | Director/Board Member | |
Cormorant Pharmaceuticals AB
![]() Cormorant Pharmaceuticals AB BiotechnologyHealth Technology Cormorant Pharmaceuticals AB provides biopharmaceutical products.The company was founded by Maarten de Chateau and Urban Paulsson in 2010 and is headquartered in Solna, Sweden. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
B&E Invest AB | Director/Board Member | ||
Chromafora AB
![]() Chromafora AB Environmental ServicesIndustrial Services Chromafora AB offers water purification and technology for selective heavy metal separation to a global market. It provides chemical reducing technology. Its services include selective metal extraction to handle waste streams containing dissolved heavy metals and chemical synthesis. The company was founded by Martin Kullberg, Karl Gaston Lavén, and Henrik Joachim Rundgren in 2010 and is headquartered in Solna, Sweden. | Environmental Services | Director/Board Member | |
Recipharm Fontaine SAS
![]() Recipharm Fontaine SAS Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm Fontaine SAS is a French pharmaceutical company that manufactures pharmaceutical products. The company is based in Fontaine-les-Dijon, France. The company was founded in 2008. Pascal Prudent has been the CEO of the company since 2017. | Pharmaceuticals: Major | Chairman | |
Linköping Institute of Technology | College/University | Graduate Degree | |
Empros Pharma AB
![]() Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Flerie Invest AB
![]() Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Consultant / Advisor Chairman | |
Trimeta LLC | Chairman | ||
B&E Participation, Inc. | Chairman | ||
Pingvinen Penningplacering AB | Director/Board Member | ||
Zentricity Holding AB
![]() Zentricity Holding AB Financial ConglomeratesFinance Zentricity Holding AB provides investment services. It offers venture capital to startup companies. The company is headquartered in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
Atrogi AB
![]() Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member Director/Board Member | |
Sixera Pharma AB
![]() Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Sixera Pharma AB conducts activities within research, development, and commercialization of pharmaceuticals. It develops treatment for Netherton syndrome. The company was founded by Jean Nordstrom on August 21, 2012 and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
Flerie Participation AB
![]() Flerie Participation AB Financial ConglomeratesFinance Flerie Participation AB is an investment holding Swedish company. The company is based in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
LIPUM AB | Biotechnology | Director/Board Member | |
Prokarium Ltd.
![]() Prokarium Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Ltd. operates as a biopharmaceutical company that focuses on developing vaccination solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases. The company is headquartered in Keele, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
Amarna Therapeutics BV
![]() Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands. | Medical/Nursing Services | Chairman | |
Binx Health Ltd.
![]() Binx Health Ltd. Miscellaneous Commercial ServicesCommercial Services Part of binx health, inc., Binx Health Ltd. is a British company that engages in research and development on biotechnology. The company is based in Trowbridge, UK. The company was founded in 2005. The CEO is Jeffrey R. Luber. | Miscellaneous Commercial Services | Director/Board Member | |
ENLIVEX THERAPEUTICS LTD. | Biotechnology | Director/Board Member Director/Board Member | |
Recipharm Verwaltungs GmbH
![]() Recipharm Verwaltungs GmbH Financial ConglomeratesFinance Part of Recipharm AB, Recipharm Verwaltungs GmbH is an investment holding German company. The company is based in Wasserburg am Inn, Germany. The CEOs of the company are Michael Isele, Thomas Bengt Eldered. | Financial Conglomerates | Chief Executive Officer | |
Prokarium Holdings Ltd.
![]() Prokarium Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Holdings Ltd. provides management services. The private company is based in London, UK. The British company was founded in 2014. Kristen Albright has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Recipharm Holdings Ltd.
![]() Recipharm Holdings Ltd. MiscellaneousMiscellaneous Recipharm Holdings Ltd. operates from a multipurpose manufacturing facility, The company was founded on August 10, 2012 and is headquartered in Ashton-Under-Lyne, the United Kingdom. | Miscellaneous | Director/Board Member | |
EpiEndo Pharmaceuticals ehf
![]() EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
Buzzard Pharmaceuticals AB
![]() Buzzard Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Buzzard Pharmaceuticals AB develops oncology drugs. The company is based in Stockholm, Sweden. The Swedish company was founded by Urban Paulsson. The CEO is Maarten de Château. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
Svezia | 24 |
Regno Unito | 10 |
Israele | 9 |
Stati Uniti | 6 |
Francia | 3 |
Settori
Health Technology | 24 |
Finance | 10 |
Commercial Services | 8 |
Consumer Services | 3 |
Communications | 2 |
Posizioni
Director/Board Member | 122 |
Chairman | 24 |
Corporate Officer/Principal | 23 |
Chief Executive Officer | 19 |
Founder | 11 |
Contatti più connessi
Insiders | |
---|---|
Thomas Bengt Eldered | 41 |
Carl-Johan Spak | 35 |
Eyal Lifschitz | 26 |
Michel Moise Habib | 23 |
Gur Roshwalb | 17 |
Sangwoo Lee | 12 |
Aron M. Knickerbocker | 11 |
Bryan Jennings | 10 |
Michael Berelowitz | 10 |
Merav Kaye | 10 |
Jennifer Minai-Azary | 6 |
Tamar Raz | 5 |
- Borsa valori
- Insiders
- Yaron Pereg
- Connessioni Società